Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDIT-CMD diltiazem trial in coronary microvascular dysfunction
2024-512030-15-00Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Coronary Small Vessel Disease (CMD) and angina pectoris comparing Diltiazem with Placebo (2 arms). Primary endpoint: Successful treatment with diltiazem based on coronary function testing. Started Apr 2024; status: completed.
02
Drugs
diltiazem
03
Conditions
Coronary Small Vessel Disease (CMD)angina pectoris
Beyond the preview
Go deeper on 2024-512030-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512030-15-00.